重症酒精性肝炎的处置策略

刘华; 韩涛

doi:10.3969/j.issn.1001-5256.2014.02.007

重症酒精性肝炎的处置策略

DOI: 10.3969/j.issn.1001-5256.2014.02.007

刘华,
韩涛

天津市第三中心医院肝内科,天津市人工细胞重点实验室,天津市肝胆疾病研究所

基金项目:

艾滋病和病毒性肝炎等重大传染病防治国家科技重大专项(2012ZX10002004-011)；天津市科委基金项目(12JCYBJC17300)；

详细信息

中图分类号: R575.1
计量
- 文章访问数: 3094
- HTML全文浏览量: 19
- PDF下载量: 728
- 被引次数: 0
出版历程
- 收稿日期: 2013-11-05
- 出版日期: 2014-02-20

Treatment strategies for severe alcoholic hepatitis

Liu Hua,
Han Tao

Department of Hepatology, Tianjin Third Central Hospital, Tianjin Key Laboratory of Artificial Cells, and Tianjin Institute of Hepatobiliary Disease

Research funding:

摘要

摘要:
重症酒精性肝炎(SAH)作为酒精性肝病中的危重症,患者多在酒精性肝炎的基础上合并肝衰竭,并发症多,病死率高,亟需优化的治疗策略以提高患者生存期。对于SAH而言,戒酒是治疗的基础,营养支持也是必要的;糖皮质激素是目前重要的治疗药物,临床上可依据Maddrey判别函数、Lille及MELD评分进行病情评估与药物疗效评价;感染及肝肾综合征等并发症的防治也是应当予以关注的;严重者可考虑早期肝移植。
- 肝炎,酒精性 /
- 糖皮质激素类 /
- 肝移植 /
- 综述
Abstract:
Severe alcoholic hepatitis ( SAH) is a severe manifestation of alcoholic liver disease, which is associated with high mortality and presence of liver failure or complications, so optimized treatment strategies are needed to improve the survival of SAH patients. For SAH, the management is based on alcohol abstinence, and nutritional support is also necessary; glucocorticoid therapy is still the key of treatment. The patient's condition and treatment outcome can be evaluated according to the Maddrey discriminant function and Lille and MELD scores. Attention should also be paid to the prevention and treatment of complications such as infection and hepatorenal syndrome. Early liver transplantation can be considered for severe patients.
- hepatitis, alcoholic /
- glucocorticoids /
- liver transplantation /
- review

HTML全文

参考文献(36)

[1]PRNA K, RAHU K.Dramatic increase in alcoholic liver cirrhosis mortality in Estonia in 1992-2008[J].Alcohol Alcohol, 2010, 45 (6) :548-551.

[2]LU XL, TAO M, LUO JY, et al.Epidemiology of alcohol and liver disease[J].Chin J Hepatol, 2002, 10 (6) :467-468. (in Chinese) 鲁晓岚, 陶明, 罗金燕, 等.饮酒与肝病流行病学调查[J].中华肝脏病杂志, 2002, 10 (6) :467-468.

[3]LI YM.Epidemiological features of alcoholic liver disease[J].J Clin Hepatol, 2012, 15 (3) :180-182. (in Chinese) 厉有名.酒精性肝病的流行病学特点[J].实用肝脏病杂志, 2012, 15 (3) :180-182.

[4] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of alcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (3) :229-232. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (3) :229-232.

[5]O'SHEA RS, DASARATHY S, MCCULLOUGH AJ.Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology.Alcoholic liver disease[J].Hepatology, 2010, 51 (1) :307-328.

[6]MATHURIN P, HADENGUE A, BATALLER R, et al.EASL clinical practical guidelines:management of alcoholic liver disease[J].J Hepatol, 2012, 57 (2) :399-420.

[7]POTTS JR, GOUBET S, HENEGHAN MA, et al.Determinants of long-term outcome in severe alcoholic hepatitis[J].Aliment Pharmacol Ther, 2013, 38 (6) :584-595.

[8]ADDOLORATO G, LEGGIO L, FERRULLI A, et al.Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis:randomised, doubleblind controlled study[J].Lancet, 2007, 370 (9603) :1915-1922.

[9]MUZYK AJ, RIVELLI SK, GAGLIARDI JP.Defining the role of baclofen for the treatment of alcohol dependence:a systematic review of the evidence[J].CNS Drugs, 2012, 26 (1) :69-78.

[10]LEGGIO L, FERRULLI A, ZAMBON A, et al.Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection[J].Addict Behav, 2012, 37 (4) :561-564.

[11]RICHARDS DA, HILL JJ, GASK L, et al.Clinical effectiveness of collaborative care for depression in UK primary care (CADET) :cluster randomised controlled trial[J].BMJ, 2013, 347:f4913.

[12] REHM J, MATHERS C, POPOVA S, et al.Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders[J].Lancet, 2009, 373 (9682) :2223-2233.

[13]UNGUR LA, NEUNER B, JOHN S, et al.Prevention and therapy of alcohol withdrawal on intensive care units:systematic review of controlled trials[J].Alcohol Clin Exp Res, 2013, 37 (4) :675-686.

[14]PLANK LD, GANE EJ, PENG S, et al.Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis:a randomized 12-month trial[J].Hepatology, 2008, 48 (2) :557-566.

[15]ALVAREZ MA, CABRE, LORENZO-ZU'N¨IGA V, et al.Combining steroids with enteral nutrition:a better therapeutic strategy for severe alcoholic hepatitis?Results of pilot study[J].Eur J Gastroentserol Hepatol, 2004, 16 (12) :1375-1380.

[16]MEZEY E, POTTER JJ, RENNIE-TANKERSLEY L, et al.A randomized placebo controlled trial of vitamin E for alcoholic hepatitis[J].J Hepatol, 2004, 40 (1) :40-46.

[17]LOUVET A, NAVEAU S, ABDELNOUR M, et al.The Lille model:a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids[J].Hepatology, 2007, 45 (6) :1348-1354.

[18]SRIKUREJA W, KYULO NL, RUNYON BA, et al.MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis[J].J Hepatol, 2005, 42 (5) :700-706.

[19]GUSTOT T, MAILLART E, BOCCI M, et al.Invasive aspergillosis in patients with severe alcoholic hepatitis[J].J Hepatol, 2014, 60 (2) :267-274.

[20]LOUVET A, WARTEL F, CASTEL H, et al.Infection in patients with severe alcoholic hepatitis treated with steroids:early response to therapy is the key factor[J].Gastroenterology, 2009, 137 (2) :541-548.

[21]KENDRICK SF, HENDERSON E, PALMER J, et al.Theophylline improves steroid sensitivity in acute alcoholic hepatitis[J].Hepatology, 2010, 52 (1) :126-131.

[22]SIDHU SS, GOYAL O, SINGLA P, et al.Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial) [J].Dig Dis Sci, 2012, 57 (6) :1664-1671.

[23]ASSIMAKOPOULOS SF, THOMOPOULOS KC, LABROPOULOUKARATZA C.Pentoxifylline:a first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?[J].World J Gastroenterol, 2009, 15 (25) :3194-3195.

[24]MATHURIN P, LOUVET A, DUHAMEL A, et al.Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis:a randomized clinical trial[J].JAMA, 2013, 310 (10) :1033-1041.

[25]SPAHR L, RUBBIA-BRANDT L, FROSSARD JL, et al.Combination of steroids with infliximab or placebo in severe alcoholic hepatitis:a randomized controlled pilot study[J].J Hepatol, 2002, 37 (4) :448-455.

[26]SHARMA P, KUMAR A, SHARMA BC, et al.Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival:an open label trial[J].J Hepatol, 2009, 50 (3) :584-591.

[27]VERMA S, AJUDIA K, MENDLER M, et al.Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events[J].Dig Dis Sci, 2006, 51 (9) :1637-1643.

[28]SALERNO F, CAZZANIGA M, MERLI M, et al.Diagnosis, treatment and survival of patients with hepatorenal syndrome:a survey on daily medical practice[J].J Hepatol, 2011, 55 (6) :1241-1248.

[29]BOYER TD, SANYAL AJ, GARCIA-TSAO G, et al.Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1:relationship of serum creatinine to hemodynamics[J].J Hepatol, 2011, 55 (2) :315-321.

[30]TESTINO G, LEONE S, FERRO C, et al.Severe acute alcoholic hepatitis and hepatorenal syndrome:role of transjugular intrahepatic portosystemic stent shunt[J].J Med Life, 2012, 5 (2) :203-205.

[31]HORIE Y.Granulocytapheresis and plasma exchange for severe alcoholic hepatitis[J].J Gastroenterol Hepatol, 2012, 27 (Suppl2) :99-103.

[32]SEN S, MOOKERJEE RP, CHESHIRE LM, et al.Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis[J].J Hepatol, 2005, 43 (1) :142-148.

[33] MATHURIN P, MORENO C, SAMUEL D, et al.Early liver transplantation for severe alcoholic hepatitis[J].N Engl J Med, 2011, 365 (19) :1790-1800.

[34]DUREJA P, LUCEY MR.The place of liver transplantation in the treatment of severe alcoholic hepatitis[J].J Hepatol, 2010, 52 (5) :759-764.

[35]SINGAL AK, KAMATH PS, GORES GJ, et al.Alcoholic Hepatitis:Current challenges and future directions[J].Clin Gastroenterol Hepatol, 2013 Jun 28.[Epub ahead of print]

[36]AMINI M, RUNYON BA.Alcoholic hepatitis 2010:a clinician's guide to diagnosis and therapy[J].World J Gastroenterol, 2010, 16 (39) :4905-4912.

施引文献

资源附件(0)

访问统计